In this article, we are going to take a look at where Johnson Controls International plc (NYSE:JCI) stands against the other stocks Jim Cramer recently talked about. Investors are pulling back ...
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.
Emergent BioSolutions (NYSE:EBS – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday. Several other equities ...